The DOI matches its Crossref record.
A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation
Open accessAbstract
We evaluated the role of granulocyte colony-stimulating factor (G-CSF) in patients with severe aplastic anemia (SAA) treated with antithymocyte globulin (ATG) and cyclosporine (CSA). Between January 2002 and July 2008, 192 patients with newly diagnosed SAA not eligible for transplantation were entered into this multicenter, randomized study to receive ATG/CSA with or without G-CSF. Overall survival (OS) at 6 years was 76% ± 4%, and event-free survival (EFS) was 42% ± 4%. No difference in OS/EFS was seen between patients randomly assigned to receive or not to receive G-CSF, neither for the entire cohort nor in subgroups stratified by age and disease severity. Patients treated with G-CSF had fewer infectious episodes (24%) and hospitalization days (82%) compared with patients without G-CSF (36%; P = .006; 87%; P = .0003). In a post hoc analysis of patients receiving G-CSF, the lack of a neutrophil response by day 30 was associated with significantly lower response rate (56% vs 81%; P = .048) and survival (65% vs 87%; P = .031). G-CSF added to standard ATG and CSA reduces the rate of early infectious episodes and days of hospitalization in very SAA patients and might allow early identification of nonresponders but has no effect on OS, EFS, remission, relapse rates, and mortality. This study was registered at www.clinicaltrials.gov as NCT01163942.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Guidelines for the diagnosis and management of adult aplastic anaemia
Killick, S. B., Bown, N., Cavenagh, J., Dokal, I., Foukaneli, T., Hill, A., Hillmen, P., Ireland, R., Kulasekararaj, A., Mufti, G., et al. (2016) · British Journal of Haematology · doi:10.1111/bjh.13853 · Cited by 749
Self-citationHow I treat acquired aplastic anemia
Scheinberg, P., & Young, N. S. (2012) · Blood · doi:10.1182/blood-2011-12-274019 · Cited by 443
How I treat acquired aplastic anemia
Bacigalupo, A. (2017) · Blood · doi:10.1182/blood-2016-08-693481 · Cited by 421
Self-citationDesmond, R., Townsley, D. M., Dumitriu, B., Olnes, M. J., Scheinberg, P., Bevans, M., Parikh, A. R., Broder, K., Calvo, K. R., Wu, C. O., et al. (2014) · Blood · doi:10.1182/blood-2013-10-534743 · Cited by 402
G-CSF and GM-CSF in Neutropenia
Mehta, H. M., Malandra, M., & Corey, S. J. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500861 · Cited by 363
Metadata
- Authors
- Tichelli, A., Schrezenmeier, H., Socié, G., Marsh, J., Bacigalupo, A., Dührsen, U., Franzke, A., Hallek, M., Thiel, E., Wilhelm, M., Höchsmann, B., Barrois, A., Champion, K., & Passweg, J. R.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2011-04-28
- Volume
- 117
- Issue
- 17
- Pages
- 4434-4441
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2020864215
- Cited by
- 219
- References
- 0
- FWCI
- 10.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation. https://app.cochat.ai/papers/10.1182/blood-2010-08-304071
- The paper
- Tichelli, A., Schrezenmeier, H., Socié, G., Marsh, J., Bacigalupo, A., Dührsen, U., Franzke, A., Hallek, M., Thiel, E., Wilhelm, M., Höchsmann, B., Barrois, A., Champion, K., & Passweg, J. R. (2011). A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation. Blood. https://doi.org/10.1182/blood-2010-08-304071
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.